This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Jine Li: Innovator in Chondroitin Sulfate Research
Introduction
Jine Li is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of chondroitin sulfate oligosaccharides. With a total of 2 patents, his work has implications for both pharmaceutical applications and therapeutic treatments.
Latest Patents
Jine Li's latest patents include innovative methods for the enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides. These methods provide high yields of structurally defined oligosaccharides ranging from 3-mers to 15-mers. Additionally, he has developed cell protective methods and compositions that utilize chondroitin sulfate compounds. These compounds are designed to treat histone toxicity and sepsis in subjects, showcasing the potential for therapeutic applications in medicine.
Career Highlights
Jine Li is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work has garnered attention for its practical applications in treating various medical conditions. His innovative approaches to synthesizing chondroitin sulfate oligosaccharides have positioned him as a key figure in his field.
Collaborations
Jine Li collaborates with esteemed colleagues such as Jian Liu and Erica Sparkenbaugh. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in biochemistry and pharmacology.
Conclusion
Jine Li's contributions to the field of chondroitin sulfate research highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing scientific knowledge and developing practical solutions for health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
